Director Julie Sunderland resigns from Compass Therapeutics Board

Compass Therapeutics, Inc.

Julie Sunderland notified the Board of her resignation effective December 31, 2021.
Resignation from the Board and all committees; not due to any disagreement with the company.
She was an early venture investor and is departing for other professional endeavors.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Julie Sunderland

Director

CMPX · Compass Therapeutics, Inc.

Effective: 2021-12-31
Filed: December 21, 2021, 6:59 PM ET

On December 20, 2021, Julie Sunderland, a member of the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”), notified the Company of her resignation from the Board and all committees thereof, effective December 31, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Julie Sunderland resigned as Director at Compass Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On December 20, 2021, Julie Sunderland, a member of the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”), notified the Company of her resignation from the Board and all committees thereof, effective December 31, 2021.

View on SEC.gov

Compass Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-21-005307

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.